Mobile

A study to compare masitinib with dexamethasone and gemcitabine in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma Un estudio para comparar masitinib con dexamet...

Update Il y a 4 ans
Reference: EUCTR2010-021091-28

A study to compare masitinib with dexamethasone and gemcitabine in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma Un estudio para comparar masitinib con dexametasona y gemcitabine en el tratamiento de pacientes con linfoma periférico de células T recidivante o refractario

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Overall Survival (OS) Supervivencia global (SG)

Inclusion criteria

  • Relapsed or Refractory Peripheral T-Cell Lymphoma,Linfoma periférico de células T recidivante o refractario

Links